A detailed history of Palisade Asset Management, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Palisade Asset Management, LLC holds 3,528 shares of BSX stock, worth $361,126. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,528
Holding current value
$361,126
% of portfolio
0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$72.96 - $84.0 $257,402 - $296,352
3,528 New
3,528 $295,000
Q1 2024

May 01, 2024

BUY
$57.6 - $68.62 $145,612 - $173,471
2,528 New
2,528 $173,000
Q4 2017

Feb 01, 2018

SELL
$24.79 - $29.8 $295,001 - $354,620
-11,900 Closed
0 $0
Q3 2017

Oct 26, 2017

BUY
$26.26 - $29.17 $312,494 - $347,123
11,900
11,900 $347,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Palisade Asset Management, LLC Portfolio

Follow Palisade Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Asset Management, LLC with notifications on news.